These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 18492116)

  • 1. Thromboelastography in children with coagulation factor deficiencies.
    Chitlur M; Warrier I; Rajpurkar M; Hollon W; Llanto L; Wiseman C; Lusher JM
    Br J Haematol; 2008 Jun; 142(2):250-6. PubMed ID: 18492116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of coagulation factor deficiency on plasma coagulation kinetics determined via thrombelastography: critical roles of fibrinogen and factors II, VII, X and XII.
    Nielsen VG; Cohen BM; Cohen E
    Acta Anaesthesiol Scand; 2005 Feb; 49(2):222-31. PubMed ID: 15715625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility of using thrombin generation assay (TGA) for monitoring bypassing agent therapy in patients with hemophilia having inhibitors.
    Ay Y; Balkan C; Karapinar DY; Akin M; Bilenoglu B; Kavakli K
    Clin Appl Thromb Hemost; 2013; 19(4):389-94. PubMed ID: 22395575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of thromboelastographic patterns with clinical presentation and rationale for use of antifibrinolytics in severe haemophilia patients.
    Ghosh K; Shetty S; Kulkarni B
    Haemophilia; 2007 Nov; 13(6):734-9. PubMed ID: 17973850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The defective down regulation of fibrinolysis in haemophilia A can be restored by increasing the TAFI plasma concentration.
    Mosnier LO; Lisman T; van den Berg HM; Nieuwenhuis HK; Meijers JC; Bouma BN
    Thromb Haemost; 2001 Oct; 86(4):1035-9. PubMed ID: 11686321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro hemostatic properties of French lyophilized plasma.
    Martinaud C; Civadier C; Ausset S; Verret C; Deshayes AV; Sailliol A
    Anesthesiology; 2012 Aug; 117(2):339-46. PubMed ID: 22739764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of natural anticoagulant and fibrinolytic factors in modulating the clinical severity of haemophilia patients.
    Shetty S; Vora S; Kulkarni B; Mota L; Vijapurkar M; Quadros L; Ghosh K
    Br J Haematol; 2007 Aug; 138(4):541-4. PubMed ID: 17659055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombin generation and clot formation in methylene blue-treated plasma and cryoprecipitate.
    Cardigan R; Philpot K; Cookson P; Luddington R
    Transfusion; 2009 Apr; 49(4):696-703. PubMed ID: 19170989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New assays for monitoring haemophilia treatment.
    Shima M; Matsumoto T; Ogiwara K
    Haemophilia; 2008 Jul; 14 Suppl 3():83-92. PubMed ID: 18510527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of plasma dilution on tissue-factor-induced thrombin generation and thromboelastography: partly compensating role of platelets.
    Schols SE; Feijge MA; Lancé MD; Hamulyák K; ten Cate H; Heemskerk JW; van Pampus EC
    Transfusion; 2008 Nov; 48(11):2384-94. PubMed ID: 18673348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of compensatory platelet activation in patients with severe haemophilia, but evidence for a platelet collagen-activation defect.
    Grünewald M; Siegemund A; Grünewald A; Konegen A; Koksch M; Griesshammer M
    Platelets; 2002 Dec; 13(8):451-8. PubMed ID: 12487778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the factor V Leiden mutation on the clinical expression of severe hemophilia A.
    Lee DH; Walker IR; Teitel J; Poon MC; Ritchie B; Akabutu J; Sinclair GD; Pai M; Wu JW; Reddy S; Carter C; Growe G; Lillicrap D; Lam M; Blajchman MA
    Thromb Haemost; 2000 Mar; 83(3):387-91. PubMed ID: 10744141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges in the laboratory analyses of bleeding disorders.
    Chitlur M
    Thromb Res; 2012 Jul; 130(1):1-6. PubMed ID: 22483776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrinogen St. Louis: a new inherited fibrinogen variant, coincidentally associated with hemophilia A.
    Sherman LA; Gaston LW; Kaplan ME; Spivack AR
    J Clin Invest; 1972 Mar; 51(3):590-7. PubMed ID: 4622105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased thrombin generation and fibrinogen level after therapeutic plasma transfusion: relation to bleeding.
    Schols SE; van der Meijden PE; van Oerle R; Curvers J; Heemskerk JW; van Pampus EC
    Thromb Haemost; 2008 Jan; 99(1):64-70. PubMed ID: 18217136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thromboelastography identifies children with rare bleeding disorders and predicts bleeding phenotype.
    Zia AN; Chitlur M; Rajpurkar M; Ozgonenel B; Lusher J; Callaghan JH; Callaghan MU
    Haemophilia; 2015 Jan; 21(1):124-32. PubMed ID: 25545302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of thromboelastography and thrombin generation assay to predict clinical phenotype in patients with severe FVII deficiency.
    Tran HT; Tjønnfjord GE; Holme PA
    Haemophilia; 2014 Jan; 20(1):141-6. PubMed ID: 23992369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colloids decrease clot propagation and strength: role of factor XIII-fibrin polymer and thrombin-fibrinogen interactions.
    Nielsen VG
    Acta Anaesthesiol Scand; 2005 Sep; 49(8):1163-71. PubMed ID: 16095459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The thrombin activation pathway modulates the assembly, structure and lysis of human plasma clots in vitro.
    Torbet J
    Thromb Haemost; 1995 May; 73(5):785-92. PubMed ID: 7482404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calibrated automated thrombin generation and modified thromboelastometry in haemophilia A.
    van Veen JJ; Gatt A; Bowyer AE; Cooper PC; Kitchen S; Makris M
    Thromb Res; 2009 Apr; 123(6):895-901. PubMed ID: 19012951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.